We are live on
!
Find out more
BS
Boenning & Scattergood Portfolio holdings
AUM
$622M
1-Year Est. Return
8.79%
This Fund
S&P 500
This Quarter
Est. Return
+18.3%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$375M
AUM Growth
+$84.6M
(+29%)
Cap. Flow
+$36.6M
Cap. Flow
% of AUM
9.77%
Top 10 Holdings %
Top 10 Hldgs %
25.67%
Holding
320
New
50
Increased
136
Reduced
67
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.06M |
| 2 |
Microsoft
MSFT
|
+$1.9M |
| 3 |
RTX Corp
RTX
|
+$1.41M |
| 4 |
CVS Health
CVS
|
+$1.09M |
| 5 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.54M |
| 2 |
Gilead Sciences
GILD
|
+$1.32M |
| 3 |
RTN
Raytheon Company
RTN
|
+$1.14M |
| 4 |
Middlesex Water
MSEX
|
+$1.02M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Healthcare | 16.08% |
| 3 | Financials | 9.22% |
| 4 | Industrials | 8.08% |
| 5 | Consumer Staples | 7.55% |
Similar funds
AAM
F
GBS
C
FPCM
TC
SAS
PIM
Boenning & Scattergood's Q2 2020 Portfolio in Review
As of Q2 2020, Boenning & Scattergood held 320 positions worth $375M, up 29% from $290M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Boenning & Scattergood deployed $36.6M of net new capital in Q2 2020, opening 50 new positions and adding to 136 existing holdings. Its largest new stake was Blackrock: 1,919 shares worth $1.04M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.32M trimmed.
- Boenning & Scattergood's largest Q2 2020 buy was Blackrock: 1,919 shares worth $1.04M.
- Boenning & Scattergood added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2020, an estimated $2.06M increase.
- Boenning & Scattergood's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $1.32M.
- Boenning & Scattergood fully exited Becton Dickinson in Q2 2020, selling an estimated $3.54M.
- Boenning & Scattergood's ten largest holdings make up 26% of its $375M portfolio in Q2 2020.
- Boenning & Scattergood opened 50 new positions and closed 16 in Q2 2020.
- Boenning & Scattergood's portfolio value rose 29% quarter-over-quarter to $375M.
Based on Boenning & Scattergood's 13F filing for Q2 2020, filed 14 Jul 2020.